BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Enzi G, Busetto L, Sergi G, Coin A, Inelmen EM, Vindigni V, Bassetto F, Cinti S. Multiple symmetric lipomatosis: a rare disease and its possible links to brown adipose tissue. Nutr Metab Cardiovasc Dis. 2015;25:347-353. [PMID: 25770761 DOI: 10.1016/j.numecd.2015.01.010] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Gao Y, Hu JL, Zhang XX, Zhang MS, Lu Y. Madelung's Disease: Is Insobriety the Chief Cause?Aesthetic Plast Surg. 2017;41:1208-1216. [PMID: 28791470 DOI: 10.1007/s00266-017-0920-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Wollina U. [Lipedema: up-to-date of a long forgotten disease]. Wien Med Wochenschr 2017;167:343-8. [PMID: 28493139 DOI: 10.1007/s10354-017-0566-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
3 Chen K, Wang L, Yang W, Wang C, Hu G, Mo Z. Profiling of differentially expressed genes in adipose tissues of multiple symmetric lipomatosis. Mol Med Rep 2017;16:6570-9. [PMID: 28901441 DOI: 10.3892/mmr.2017.7437] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Martin R, Shapiro JI. Role of adipocytes in hypertension. World J Hypertens 2016; 6(2): 66-75 [DOI: 10.5494/wjh.v6.i2.66] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Wanke J, Yongjing F. A case report of Madelung's disease in China. Radiol Case Rep 2022;17:320-5. [PMID: 34876958 DOI: 10.1016/j.radcr.2021.10.035] [Reference Citation Analysis]
6 Gilson RC, Osswald S. Madelung lipomatosis presenting as a manifestation of myoclonic epilepsy with ragged red fibers (MERRF) syndrome. JAAD Case Rep 2018;4:822-3. [PMID: 30238046 DOI: 10.1016/j.jdcr.2018.05.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Cinti S. Adipose Organ Development and Remodeling. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 1357-431. [DOI: 10.1002/cphy.c170042] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 10.8] [Reference Citation Analysis]
8 Prantl L, Schreml J, Gehmert S, Klein S, Bai X, Zeitler K, Schreml S, Alt E, Gehmert S, Felthaus O. Transcription Profile in Sporadic Multiple Symmetric Lipomatosis Reveals Differential Expression at the Level of Adipose Tissue-Derived Stem Cells. Plast Reconstr Surg 2016;137:1181-90. [PMID: 27018673 DOI: 10.1097/PRS.0000000000002013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
9 Tsilivigkos C, Mastronikolis S, Lygeros S, Tsilimpoti D, Papadas T. Multiple symmetric lipomatosis (Madelung's disease) with symptoms and signs of hypertension, lipodystrophy, and dyspnea: A case report and literature review. Clin Case Rep 2021;9:e04288. [PMID: 34194793 DOI: 10.1002/ccr3.4288] [Reference Citation Analysis]
10 Jung K, Lee S. A case report of Multiple Symmetric Lipomatosis (MSL) in an East Asian Female. BMC Womens Health 2020;20:200. [PMID: 32928192 DOI: 10.1186/s12905-020-01055-w] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sanna M, Borgo C, Compagnin C, Favaretto F, Vindigni V, Trento M, Bettini S, Comin A, Belligoli A, Rugge M, Bassetto F, Donella-Deana A, Vettor R, Busetto L, Milan G. White Adipose Tissue Expansion in Multiple Symmetric Lipomatosis Is Associated with Upregulation of CK2, AKT and ERK1/2. Int J Mol Sci 2020;21:E7933. [PMID: 33114687 DOI: 10.3390/ijms21217933] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Gozzo C, Galioto F, Palmucci S, Signorelli SS, Basile A. A non-alcohol-related case of Madelung's disease: Challenging patient with progressive jugular vein distension. Radiol Case Rep 2021;16:1183-7. [PMID: 33777283 DOI: 10.1016/j.radcr.2021.02.050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Li B, Rang ZX, Weng JC, Xiong GZ, Dai XP. Benign symmetric lipomatosis (Madelung’s disease) with concomitant incarcerated femoral hernia: A case report. World J Clin Cases 2020; 8(21): 5474-5479 [PMID: 33269286 DOI: 10.12998/wjcc.v8.i21.5474] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Moonen MPB, Nascimento EBM, van Kroonenburgh MJPG, Brandjes D, van Marken Lichtenbelt WD. Absence of 18 F-fluorodeoxyglucose uptake using Positron Emission Tomography/Computed Tomography in Madelung's disease: A case report. Clin Obes 2019;9:e12302. [PMID: 30815996 DOI: 10.1111/cob.12302] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Karashima S, Yoneda T. Madelung disease in a 58-year-old man.CMAJ. 2019;191:E48. [PMID: 30642826 DOI: 10.1503/cmaj.180759] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Wan SC, Huang MH, Perng CK, Liao WC. Madelung Disease: Analysis of Clinicopathological Experience in Taipei Veterans General Hospital. Ann Plast Surg 2019;82:S66-71. [PMID: 30461459 DOI: 10.1097/SAP.0000000000001719] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
17 Sanchez-Gurmaches J, Martinez Calejman C, Jung SM, Li H, Guertin DA. Brown fat organogenesis and maintenance requires AKT1 and AKT2. Mol Metab 2019;23:60-74. [PMID: 30833219 DOI: 10.1016/j.molmet.2019.02.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
18 Szewc M, Sitarz R, Moroz N, Maciejewski R, Wierzbicki R. Madelung's disease - progressive, excessive, and symmetrical deposition of adipose tissue in the subcutaneous layer: case report and literature review. Diabetes Metab Syndr Obes 2018;11:819-25. [PMID: 30538518 DOI: 10.2147/DMSO.S181154] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
19 Rocha N, Bulger DA, Frontini A, Titheradge H, Gribsholt SB, Knox R, Page M, Harris J, Payne F, Adams C, Sleigh A, Crawford J, Gjesing AP, Bork-Jensen J, Pedersen O, Barroso I, Hansen T, Cox H, Reilly M, Rossor A, Brown RJ, Taylor SI, McHale D, Armstrong M, Oral EA, Saudek V, O'Rahilly S, Maher ER, Richelsen B, Savage DB, Semple RK. Human biallelic MFN2 mutations induce mitochondrial dysfunction, upper body adipose hyperplasia, and suppression of leptin expression. Elife 2017;6:e23813. [PMID: 28414270 DOI: 10.7554/eLife.23813] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 6.2] [Reference Citation Analysis]
20 Felthaus O, Schön T, Schiltz D, Aung T, Kühlmann B, Jung F, Anker A, Klein S, Prantl L. Adipose tissue-derived stem cells from affected and unaffected areas in patients with multiple symmetric lipomatosis show differential regulation of mTOR pathway genes. Clin Hemorheol Microcirc 2018;69:141-51. [PMID: 29758934 DOI: 10.3233/CH-189107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Tian M, Liu Y, Zhi Z, Li Y. Multiple symmetric lipomatosis and gynecomastia: A case report and relative literature review. J Clin Lipidol 2017;11:763-7. [PMID: 28438575 DOI: 10.1016/j.jacl.2017.03.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
22 López-Gallardo E, Cammarata-Scalisi F, Emperador S, Hernández-Ainsa C, Habbane M, Vela-Sebastián A, Bayona-Bafaluy MP, Montoya J, Ruiz-Pesini E. Mitochondrial DNA pathogenic mutations in multiple symmetric lipomatosis. Clin Genet 2020;97:731-5. [PMID: 31912494 DOI: 10.1111/cge.13701] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
23 Chen KK, Ni LS, Yu WH. Madelung disease: A case report. World J Clin Cases 2021; 9(8): 1983-1988 [PMID: 33748250 DOI: 10.12998/wjcc.v9.i8.1983] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Wu L, Jiang T, Zhang Y, Tang AQ, Wu LH, Liu Y, Li MQ, Zhao LB. Madelung’s disease with alcoholic liver disease and acute kidney injury: A case report. World J Clin Cases 2021; 9(27): 8199-8206 [PMID: 34621881 DOI: 10.12998/wjcc.v9.i27.8199] [Reference Citation Analysis]
25 Al Ghazal P, Grönemeyer LL, Schön MP. Lipomatoses. J Dtsch Dermatol Ges 2018;16:313-27. [PMID: 29431910 DOI: 10.1111/ddg.13460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Al Ghazal P, Grönemeyer LL, Schön MP. Lipomatosen. J Dtsch Dermatol Ges 2018;16:313-28. [PMID: 29537156 DOI: 10.1111/ddg.13460_g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Ma W, Zhao X, Li X, Zang C, Yang L, Wang Y, Liu X. Madelung's disease and pulmonary aspergillosis: a case report and literature review. J Cardiothorac Surg 2020;15:114. [PMID: 32450893 DOI: 10.1186/s13019-020-01166-3] [Reference Citation Analysis]
28 Gao H, Xin ZY, Yin X, Zhang Y, Jin QL, Wen XY. Madelung disease: A case report. Medicine (Baltimore). 2019;98:e14116. [PMID: 30653136 DOI: 10.1097/md.0000000000014116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
29 Araújo de Melo Campos JT, Dantas de Medeiros JL, Cardoso de Melo ME, Alvares da Silva M, Oliveira de Sena M, Sales Craveiro Sarmento A, Fassarella Agnez Lima L, de Freitas Fregonezi GA, Gomes Lima J. Endoplasmic reticulum stress and muscle dysfunction in congenital lipodystrophies. Biochim Biophys Acta Mol Basis Dis 2021;1867:166120. [PMID: 33713793 DOI: 10.1016/j.bbadis.2021.166120] [Reference Citation Analysis]
30 Capel E, Vatier C, Cervera P, Stojkovic T, Disse E, Cottereau AS, Auclair M, Verpont MC, Mosbah H, Gourdy P, Barraud S, Miquel A, Züchner S, Bonnefond A, Froguel P, Christin-Maitre S, Delemer B, Fève B, Laville M, Robert J, Tenenbaum F, Lascols O, Vigouroux C, Jéru I. MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue. J Clin Lipidol 2018;12:1420-35. [PMID: 30158064 DOI: 10.1016/j.jacl.2018.07.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
31 Lentini A, Ciccarelli O, Bonaccorsi Riani E, Coubeau L, Revencu N, Dahlqvist G, Lengelé B. Exceptional manifestation of Madelung's disease after liver transplantation. Acta Gastroenterol Belg 2022;85:102-4. [PMID: 35305001 DOI: 10.51821/85.1.8308] [Reference Citation Analysis]
32 Schiltz D, Anker A, Ortner C, Tschernitz S, Koller M, Klein S, Felthaus O, Schreml J, Schreml S, Prantl L. Multiple Symmetric Lipomatosis: New Classification System Based on the Largest German Patient Cohort. Plast Reconstr Surg Glob Open 2018;6:e1722. [PMID: 29876171 DOI: 10.1097/GOX.0000000000001722] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
33 Wollina U, Heinig B. Madelung's Disease - Case Series and Treatment by Tumescent Liposuction or Lipectomy. Open Access Maced J Med Sci 2017;5:427-31. [PMID: 28785324 DOI: 10.3889/oamjms.2017.114] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
34 Caponnetto F, Manini I, Bulfoni M, Zingaretti N, Miotti G, Di Loreto C, Cesselli D, Mariuzzi L, Parodi PC. Human Adipose-Derived Stem Cells in Madelung's Disease: Morphological and Functional Characterization. Cells 2020;10:E44. [PMID: 33396896 DOI: 10.3390/cells10010044] [Reference Citation Analysis]
35 Maximiano LF, Gaspar MT, Nakahira ES. Madelung disease (multiple symmetric lipomatosis). Autops Case Rep. 2018;8:e2018030. [PMID: 30101135 DOI: 10.4322/acr.2018.030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Perera U, Kennedy BA, Hegele RA. Multiple Symmetric Lipomatosis (Madelung Disease) in a Large Canadian Family With the Mitochondrial MTTK c.8344A>G Variant.J Investig Med High Impact Case Rep. 2018;6:2324709618802867. [PMID: 30283804 DOI: 10.1177/2324709618802867] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
37 Chen K, Wan X, Zhao L, Zhao S, Peng L, Yang W, Yuan J, Zhu L, Mo Z. Cbl Proto-Oncogene B (CBLB) c.197A>T Mutation Induces Mild Metabolic Dysfunction in Partial Type I Multiple Symmetric Lipomatosis (MSL). Diabetes Metab Syndr Obes 2020;13:3535-49. [PMID: 33116705 DOI: 10.2147/DMSO.S273780] [Reference Citation Analysis]